Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism · 12.07.2024 · 109 (8) · 2097-2105
DOI: 10.1210/clinem/dgae009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 24.01.2024. Verfasst von Ping-Shaou Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohs…. Hauptthemen laut MEDLINE: Methylamines, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Disease Progression. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan, National Science and Technology Council, Kaohsiung Medical University, Kaohsiung, Taiwan.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Type 2 diabetes (T2D) is the major contributor to chronic kidney disease and end-stage kidney disease (ESKD). The influence of trimethylamine N-oxide (TMAO) on kidney outcomes in T2D remains unclear.
Objective
To examine the association between fasting serum TMAO levels and adverse kidney outcomes in patients with T2D.
Methods
Between October 2016 and June 2020, patients with T2D were recruited and monitored every 3 months until December 2021. Serum TMAO levels were assessed using liquid chromatography-mass spectrometry. The primary kidney outcomes were doubling of serum creatinine levels or progression to ESKD necessitating dialysis; the secondary kidney outcome was a rapid 30% decline in estimated glomerular filtration rate within 2 years. All-cause mortality was also evaluated.
Results
Among the 440 enrolled patients with T2D, those in the highest serum TMAO tertile (≥0.88 μM) were older, had a longer diabetes duration, elevated blood urea nitrogen, and lower estimated glomerular filtration rate. Over a median follow-up period of 4 years, 26 patients (5.9%) had a doubling of serum creatinine level or progression to ESKD. After propensity score weighting, the patients in the highest serum TMAO tertile had a 6.45-fold increase in the risk of doubling of serum creatinine levels or progression to ESKD and 5.86-fold elevated risk of rapid decline in kidney function compared with those in the lowest tertile. Additionally, the stepwise increase in serum TMAO was associated with all-cause mortality.
Conclusion
Patients with T2D with elevated circulating TMAO levels are at higher risk of doubling serum creatinine, progressing to ESKD, and mortality. TMAO is a potential biomarker for kidney function progression and mortality in patients with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Internal Medicine, Kaohsiung Municipal Cijin Hospital, Kaohsiung 805, Taiwan.
- Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
ORCID-Profile: Ping-Shaou Yu, Ping-Hsun Wu, Wei-Wen Hung, Ming-Yen Lin, Wei-Chun Hung, Jer-Ming Chang, Jong-Rung Tsai, Yi-Wen Chiu, Shang-Jyh Hwang, Yi-Chun Tsai
Förderung
- Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
- National Science and Technology Council
- Kaohsiung Medical University, Kaohsiung, Taiwan
- Kaohsiung Municipal Cijin Hospital, Kaohsiung, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Zitieren
APA
Yu, P. S., Wu, P. H., Hung, W. W., Lin, M. Y., Zhen, Y. Y., Hung, W. C., Chang, J. M., Tsai, J. R., Chiu, Y. W., Hwang, S. J., & Tsai, Y. C. (2024). Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism, 109(8), 2097-2105. https://doi.org/10.1210/clinem/dgae009
Vancouver
Yu PS, Wu PH, Hung WW, Lin MY, Zhen YY, Hung WC, et al. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 2024;109(8):2097-2105. doi:10.1210/clinem/dgae009
BibTeX
@article{Yu2024,
author = {Yu, Ping-Shaou and Wu, Ping-Hsun and Hung, Wei-Wen and Lin, Ming-Yen and Zhen, Yen-Yi and Hung, Wei-Chun and Chang, Jer-Ming and Tsai, Jong-Rung and Chiu, Yi-Wen and Hwang, Shang-Jyh and Tsai, Yi-Chun},
title = {Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {8},
pages = {2097--2105},
doi = {10.1210/clinem/dgae009}
}
EUVIMED